Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Knowns and unknowns in the care of pediatric familial hypercholesterolemia

13 Jul 2017

Abstract excerpt

Familial hypercholesterolemia (FH) is a common genetic disorder that causes elevated LDL cholesterol levels from birth. Untreated FH accelerates atherosclerosis and predisposes individuals to premature coronary artery disease (CAD) in adulthood. Mendelian randomization studies have demonstrated that LDL cholesterol has both a causal and cumulative effect on the risk of CAD. This supports clinical recommendations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Genetic factors in colorectal cancer
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28701353
DOI: 10.1194/jlr.s074039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Knowns and unknowns in the care of pediatric familial hypercholesterolemiaPMID 28701353Read ↗

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.Semantic proximity Read ↗

Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.Semantic proximity Read ↗

Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.Semantic proximity Read ↗

Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert PanelSemantic proximity Read ↗

Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.Semantic proximity Read ↗

Clinical inquiries. When should we screen children for hyperlipidemia?Semantic proximity Read ↗

Lipid Screening, Action, and Follow-up in Children and Adolescents.Semantic proximity Read ↗

Familial Hypercholesterolemia: From Clinical Suspicion to Novel TreatmentsSemantic proximity Read ↗

Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care.Semantic proximity Read ↗

Population-Based Screening in Children For Early Diagnosis and Treatment of Familial Hypercholesterolemia: Design of The VRONI StudySemantic proximity Read ↗

Familial hypercholesterolemia from children to adults.Semantic proximity Read ↗

[Familial hypercholesterolemia in children and adolescents].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.